Viewing Study NCT04291105

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2026-03-08 @ 11:20 PM
Study NCT ID: NCT04291105
Status: RECRUITING
Last Update Posted: 2025-03-26
First Post: 2020-02-25
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
Sponsor: Vyriad, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
None Head and Neck Squamous Cell Carcinoma View
None Colo-rectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Solid Tumor View